Geneva Capital Management LLC trimmed its position in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 7.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 700,450 shares of the technology company’s stock after selling 58,428 shares during the quarter. Novanta makes up 2.8% of Geneva Capital Management LLC’s holdings, making the stock its 8th biggest holding. Geneva Capital Management LLC owned approximately 1.85% of Novanta worth $99,597,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. State Street Corp raised its holdings in Novanta by 7.3% in the 2nd quarter. State Street Corp now owns 1,436,785 shares of the technology company’s stock valued at $233,005,000 after buying an additional 97,621 shares during the last quarter. Tidal Investments LLC boosted its position in Novanta by 615.8% during the 2nd quarter. Tidal Investments LLC now owns 34,631 shares of the technology company’s stock worth $5,619,000 after buying an additional 29,793 shares during the period. Bank of America Corp DE grew its holdings in Novanta by 18.3% during the 1st quarter. Bank of America Corp DE now owns 456,241 shares of the technology company’s stock worth $53,887,000 after acquiring an additional 70,728 shares during the last quarter. Oppenheimer Asset Management Inc. bought a new stake in Novanta during the 2nd quarter worth approximately $5,797,000. Finally, Bamco Inc. NY bought a new stake in Novanta during the 2nd quarter worth approximately $137,984,000. 98.35% of the stock is currently owned by institutional investors.
Novanta Stock Performance
Shares of NOVT stock opened at $118.88 on Monday. Novanta Inc. has a 1-year low of $98.27 and a 1-year high of $176.38. The company has a current ratio of 1.18, a quick ratio of 0.76 and a debt-to-equity ratio of 0.48. The stock has a market cap of $4.50 billion, a price-to-earnings ratio of 90.75, a PEG ratio of 2.58 and a beta of 1.71. The stock has a 50-day moving average of $140.29 and a 200-day moving average of $142.25.
Novanta (NASDAQ:NOVT – Get Free Report) last posted its quarterly earnings data on Monday, November 9th. The technology company reported $1.05 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.08. Novanta had a return on equity of 10.23% and a net margin of 4.89%. The company had revenue of $305.01 million for the quarter, compared to analyst estimates of $301.02 million. During the same period in the previous year, the firm earned $0.87 earnings per share. The firm’s quarterly revenue was up 23.1% on a year-over-year basis. On average, equities research analysts forecast that Novanta Inc. will post 3.68 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several equities analysts have issued reports on the stock. Wall Street Zen cut shares of Novanta from a “buy” rating to a “hold” rating in a research report on Sunday. Zacks Research lowered shares of Novanta from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 6th. Weiss Ratings lowered shares of Novanta from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday, November 10th. Finally, Robert W. Baird reduced their price objective on shares of Novanta from $194.00 to $175.00 and set an “outperform” rating on the stock in a research note on Thursday. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $175.00.
View Our Latest Report on NOVT
About Novanta
Novanta develops and manufactures precision technologies used in medical and advanced industrial applications. Its products include photonics and laser components, precision motion-control systems, machine-vision technologies, and related equipment and software. The company’s technologies are used in areas such as medical and surgical systems, life sciences, robotics, and industrial automation. Novanta serves customers internationally, with operations and customers across North America, Europe, and Asia.
Featured Stories
- Five stocks we like better than Novanta
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
